Answers are grounded in this paper and cite their sources.
In early 1990s, Paul Talalay (1923–2019) and his associates have screened a wide variety of vegetables for their capability to induce the activity of NAD(P)H:quinone oxidoreductase (NQO1), a prototypic antioxidant and carcinogen-detoxifying enzyme. Among them, broccoli was found to be the most powerful inducer of this particular enzyme (Prochaska, Santamaria, & Talalay, 1992). Later, sulforaphane has been identified as a principal bioactive ingredient. Interestingly, broccoli sprout has much higher capacity of inducing NQO1 activity as well as producing sulforaphane than the mature broccoli (Yagishita, Fahey, Dinkova-Kostova, & Kensler, 2019; Zhang, Talalay, Cho, & Posner, 1992). Since then, numerous investigations have followed to evaluate the cancer chemopreventive potential of sulforaphane as well as broccoli (sprout) extract (Yagishita, Fahey, Dinkova-Kostova, & Kensler, 2019, and references there in). Epidemiological evidence suggests that consumption of broccoli is inversely associated with risk of cancer development at various sites, including prostate, breast, stomach, and colon (Becker & Juvik, 2016; Higdon, Delage, Williams, & Dashwood, 2007). The epidemiological links of broccoli consumption to the cancer preventive benefits in humans have been supported by laboratory and small-scale clinical studies (Becker & Juvik, 2016; Houghton, Fassett, & Coombes, 2016;). Such protective effects have been largely attributed to isothiocyanates including sulforaphane (James et al., 2012; Juge, Mithen, & Traka, 2007; Leone et al., 2017). Several clinical trials have been conducted to evaluate the effectiveness of sulforaphane for chemoprevention, most of which have investigated bioavailability, safety, and tolerance in healthy subjects (Ferreira et al., 2018; Kamal, Akter, Lin, & Nazzal, 2020; Leone et al., 2017; Shapiro et al., 2006). The results of phase-1 clinical trials indicated no significant toxicities or clinical symptoms of adverse effects associated with the ingestion of sulforaphane or broccoli sprout extract formulations. Residents in Qidong, People's Republic of China, are at high risk for development of hepatocellular carcinoma, in part, due to consumption of aflatoxin B1-contaminated foods. In a randomized, placebo-controlled chemoprevention trial with hot water infusions of broccoli sprouts containing defined concentrations of glucosinolate (a precursor of isothiocyanates including sulforaphane), an inverse association was observed between excretion of dithiocarbamates (sulforaphane metabolites) and aflatoxin B1-DNA adducts in individuals receiving broccoli sprout juice (Kensler et al., 2005). So far, chemoprevention trials with sulforaphane have focused on prostate cancer chemoprevention (Ferreira et al., 2018). In a double-blinded, randomized, placebo-controlled multicenter trial in patients with increasing prostate-specific antigen (PSA) levels after radical prostatectomy, daily oral administration of 60 mg of sulforaphane for 6 months significantly delayed the increases in the PSA levels (Cipolla et al., 2015). In another randomized double-blinded intervention study, consumption of a glucoraphanin-rich broccoli soup for 1 year mitigated an escalation in the expression of genes involved in potentially oncogenic pathways in men with localized prostate cancer (Traka et al., 2019). Further information on clinical trials with sulforaphane and sulforahane-containing/releasing formulations are available in the database of the U.S. National Library of Medicine (https://clinicaltrials.gov). In broccoli and other cruciferous vegetables of the Brassicaceae family, sulforaphane is present in a biologically inactive precursor form of glucoraphanin, such as 4-methylsulphinylbutyl glucosinolate (Houghton, Fassett, & Coombes, 2013; Leone et al., 2017). Glucosinolates can undergo enzymatic hydrolysis by the vegetables’ intrinsic myrosinase to release bioactive isothiocyanate metabolites including sulforaphane as degradation products. Glucosinolates are stored in the vacuoles of vegetable cells and are physically separated from the myrosinase. However, lesions of vegetable tissues during the chewing, digestive process, and/or microbial attack in the rumen facilitate the physical contact of glucosinolates with this enzyme (Ferreira et al., 2018). The hydrolysis of glucosinolates is also performed by the catalytical isoform (thioglucoside glucohydrolase) found in the gut microflora. Cooking causes denaturation of myrosinase, and in that case bacterial enzyme in the human intestine will degrade ingested intact glucosinolate to produce sulforaphane (Ferreira et al., 2018). Nonetheless, the bioavailability of sulforaphane derived from steamed broccoli is significantly lower, compared with that achieved with fresh one. Thus, cooking broccoli may reduce the chemopreventive efficacy and other health beneficial effects (Conaway et al., 2000). Sulforaphane is passively absorbed and undergoes rapid conjugation with reduced glutathione (GSH) by glutathione S-transferase, then metabolized sequentially and excreted in the urine as a mercapturic acid form (Egner et al., 2011). Sulforaphane has been extensively studied to uncover the mechanisms behind the observed chemopreventive as well as chemoprotective effects that broccoli exert. The primary mechanism is thought to be Nrf2-mediated induction of carcinogen detoxifying/antioxidant enzymes that stimulate neutralization/removal of carcinogens and their reactive metabolites or potentiate the physiologic defense against oxidative DNA damage (Houghton, Fassett, & Coombes, 2016; James et al., 2012; Russo et al., 2018; Yang, L., Palliyaguru, D. L., & Kensler, 2016). However, other mechanisms have been identified, and the list is expanding to the level covering almost all processes of multistage carcinogenesis (Ferreira et al., 2018; Houghton, 2019; Juge, Mithen, & Traka, 2007; Kamal, M., Akter, S., Lin, C.-N., & Nazzal, 2020; Leone et al., 2017). Besides its effects on the signal transduction mediated by oncogens or tumor suppressor genes, epigenetic regulation is also of importance in cancer chemoprevention with sulforaphane (Atwell et al., 2015; Tortorella, Royce, Licciardi, & Karagiannis, 2015). It is interesting to note that sulforaphane induces epigenetic regulation of Nrf2 expression presumably by promoting demethylation of the gene promoter (Zhou et al., 2019). Though broccoli sprout is acknowledged as an excellent source of sulforaphane, it is generally consumed at levels that may not be sufficiently high enough to provide cancer preventive benefits (through activation of Nrf2 signaling). Further, repeated intake of raw broccoli had no impact on the pharmacokinetic behavior or plasma levels of sulforaphane, compared with single intake (Hanlon, Coldham, Gielbert, Sauer, & Ioannides, 2009). Moreover, the content of bioactive components of broccoli varies substantially. For instance, the content of glucosinolates in the same 50 varieties of broccoli varies approximately 20-fold (Jeffery et al., 2003). In this context, an appropriately validated concentrated dry powder of broccoli sprout may be considered to supply physiologically achievable concentrations of sulforaphane as a chemopreventive principle. Although glucosinolate can be hydrolyzed by gut bacterial enzyme to form sulforaphane (Kensler et al., 2005), the yield may not be high, and there should be individual variations, depending on the constitutive expression levels of the enzyme. Therefore, such sulforaphane-yielding broccoli sprout supplement must retain both the precursor compound, glucoraphanin, and the myrosinase (Houghton, Fassett, & Coombes, 2013). Plants have evolved ubiquitous mechanisms to manage a wide spectrum of stressors and noxious conditions. According to Bruce Ames, “99.99% (by weight) of the pesticides in the American diet are chemicals that plants produce (Ames, Profet, & Gold, 1990).” Many of such plant toxins (“phytoalexins”) are produced as secondary metabolites to deter or impede pest attack, insect infestation, microbial infection, etc. and help survive other harsh environmental conditions (Becker & Juvik, 2016). The levels of these plant defense substances greatly increase when plants are stressed or damaged (Ames, Profet, & Gold, 1990), occasionally to levels that can be acutely toxic even to humans. However, at the relatively low doses (normalized to the body weight) consumed by humans, the same “toxic” phytochemicals can provoke mild stress and consequently induce adaptive cellular stress-survival responses (Surh, 2011). One key molecule that plays a central role in physiological stress response is Nrf2, an evolutionarily conserved transcription factor ubiquitously present in most species of both plant and animal kingdoms (Loboda, Damulewicz, Pyza, Jozkowicz, & Dulak, 2016; Motohashi & Yamamoto, 2004). Sulforaphane is a representative phytoalexin capable of activating Nrf2. Sulforaphane is primarily an electrophilic molecule. Once absorbed, it spontaneously reacts with GSH, with concomitant generation of moderate amounts of reactive oxygen species (ROS), disrupting the cellular redox homeostasis. The resulting transient oxidative stress triggers a rapid activation of Nrf2, thereby inducing antioxidant and other cytoprotective gene transcription as an adaptive stress-survival response. This will restore the cellular redox balance (Ferreira et al., 2018). It is now evident that the extent and duration of the ROS exposure differentially contribute to tumor formation or cellular damage and cell death (Sova & Saso, 2018). Therefore, ROS can cause either cancer-initiating DNA damage and genomic instability, or apoptotic/necrotic cell death, depending on the severity of oxidative stress it provokes. Under normal conditions, Nrf2 regulates cellular redox homeostasis and protects cells from oxidative death as well as genotoxic damage. In cancer cells, the threshold of ROS is generally higher than that in normal cells. To counteract the excessive ROS-mediated oxidative stress, cancer cells hijack the Nrf2-mediated antioxidant defense-signaling pathways. Constitutive overactivation of Nrf2 creates a tumor microenvironment that favors the survival of cancer cells by protecting them from excessive oxidative stress induced by chemotherapeutic agents or radiotherapy (Jaramillo & Zhang, 2013; Menegon, Columbano, & Menegon, 2016; Xiang, Namani, Wu, Wang, & Xiang, 2016). Nrf2 also upregulates the expression of multidrug resistance family proteins responsible for cancer cell survival through tolerance to the chemo- and radiotherapy (Hayashi, Suzuki, Itoh, Yamamoto, & Sugiyama, 2003; Vollrath, Wielandt, Iruretagoyena, Chianale, & Vollrath, 2006). As sulforaphane is a potent Nrf2 activator, cancer patients may be concerned about whether they may eat broccoli or refrain from it during treatment. However, in most of tumors, Nrf2 is already hyperactivated. Therefore, additional activation of this redox-sensitive transcription factor by sulforaphane may have a marginal effect, if any, on the redox status as well as growth of cancer cells. Considering cancer cells are, in general, adapted to excessive ROS conditions (Kim, Kim, & Seo, 2019), they are supposed to be more vulnerable to oxidative stress whereas exogenous ROS scavengers, such as N-acetyl cysteine and vitamin E, may support their growth and survival (Chio & Tuveson, 2017). ROS-inducing anticancer strategies are based on the premise that increasing the ROS level over the cytotoxic threshold can selectively kill cancer cells (Kim, Kim, & Seo, 2019). In this context, it is noticeable that sulforaphane has a pro-oxidant capacity as it directly captures GSH. Indeed, sulforaphane when treated to cancer cells generate ROS, thereby killing them via apoptosis (Sestili & Fimognari, 2015). If this effect can be verified in the cancer patients, they may benefit from eating broccoli, which raises the level of oxidative stress, an Achilles' heel of the tumor. Sulforaphane increased the effect of gemcitabine, cisplatin, doxorubicin, 5-fluorouracil, and sorafenib, for growth inhibition of tumor xenografts (Kallifatidis et al., 2011). Potentiation of efficacy of doxorubicin and cisplatin, and mitigation of their toxic effects by sulforaphane have also been recently reported (Calcabrini, Maffei, Turrini, & Fimognari, 2020). However, the use of sulforaphane in combination with immunotherapies may not be advisable as it blocks the T cell-mediated immune response required for immune surveillance of tumors. Thus, sulforaphane could interfere with the successful application of immunotherapy by immune checkpoint inhibitors (e.g., CTLA-4 antibodies and PD-1/PD-L1 antibodies) or CAR T cells (Liang, Hansch, Hubner, & Samstag, 2019). Therefore, it remains still elusive whether Nrf2 activators like sulforaphane are good, bad or ugly in the management of cancer. Precise assessment of the effects of sulforaphane on the Nrf2 activation and redox status in tumors versus surrounding normal tissues and also in the different stages of multistep carcinogenesis may help clarify this controversy.
No takes yet. Share an insight, caveat, or question.
Young‐Joon Surh (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: